Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001519114 | SCV001727924 | benign | not provided | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002276755 | SCV002564932 | uncertain significance | Osteogenesis imperfecta | 2020-07-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002501818 | SCV002794574 | likely benign | Bone mineral density quantitative trait locus 1; Exudative vitreoretinopathy 4; Exudative vitreoretinopathy 1; Worth disease; Autosomal dominant osteopetrosis 1; Osteoporosis with pseudoglioma; Osteoporosis; Polycystic liver disease 4 with or without kidney cysts | 2021-09-21 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV001519114 | SCV001922412 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001519114 | SCV001965838 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001519114 | SCV002034216 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003908857 | SCV004720474 | likely benign | LRP5-related disorder | 2021-03-25 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |